All In Biotech

Drug Trial Radar · NCT02490787

Trial Investigating Safety, Pharmacokinetics and Pharmacodynamics of Concizumab Administered Subcutaneously to Haemophilia A Subjects

A Multi-centre, Randomised, Placebo Controlled, Double Blinded, Multiple Dose Trial Investigating Safety, Pharmacokinetics and Pharmacodynamics of Concizumab Administered Subcutaneously to Haemophilia A Subjects (Explorer™3)

Last checked: Nov 20, 2026Latest source record: Jul 21, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

24

Actual

Start

Sep 10, 2015

Primary completion

Oct 14, 2016

Study completion Oct 14, 2016

Sponsor

Lead sponsor
Novo Nordisk A/SNovo Nordisk (NVO)
Sponsor type
Industry
First posted
Jul 7, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Single group
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
Male only, from 18 years, up to 64 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This trial is conducted globally. The aim of this trial is to investigate safety, pharmacokinetics (the exposure of the trial drug in the body) and pharmacodynamics (the effect of the investigated drug on the body) of concizumab administered subcutaneously to haemophilia A subjects.

Conditions

  • Congenital Bleeding Disorder
  • Haemophilia A

Interventions

  • ConcizumabDrug

    Administered subcutaneously (s.c., under the skin) at five different dose levels (ranging from 0.25 to 1.5 mg/kg)

  • placeboDrug

    Administered subcutaneously (s.c., under the skin)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of adverse events (AEs)Time frame: From first trial drug administration (day 1) to 11 weeks after the first trial product administration

Locations

34 sites in 15 countries. Site status is shown where the registry gives one.

  • Novo Nordisk Investigational Site

    Torrance, California

  • Novo Nordisk Investigational Site

    Indianapolis, Indiana

  • Novo Nordisk Investigational Site

    Iowa City, Iowa

  • Novo Nordisk Investigational Site

    Baltimore, Maryland

  • Novo Nordisk Investigational Site

    New York, New York

  • Novo Nordisk Investigational Site

    Portland, Oregon

  • Novo Nordisk Investigational Site

    Houston, Texas

  • Novo Nordisk Investigational Site

    Milwaukee, Wisconsin

  • Novo Nordisk Investigational Site

    Camperdown, New South Wales, Australia

  • Novo Nordisk Investigational Site

    Melbourne, Victoria, Australia

  • Novo Nordisk Investigational Site

    Vienna, Austria

  • Novo Nordisk Investigational Site

    Zagreb, Croatia

  • Novo Nordisk Investigational Site

    Bron, France

  • Novo Nordisk Investigational Site

    Nantes, France

  • Novo Nordisk Investigational Site

    Rennes, France

  • Novo Nordisk Investigational Site

    Berlin, Germany

  • Novo Nordisk Investigational Site

    Duisburg, Germany

  • Novo Nordisk Investigational Site

    Homburg, Germany

  • Novo Nordisk Investigational Site

    Tel HaShomer, Israel

  • Novo Nordisk Investigational Site

    Kuala Lumpur, Malaysia

  • Novo Nordisk Investigational Site

    Kuching, Malaysia

  • Novo Nordisk Investigational Site

    Amsterdam, Netherlands

  • Novo Nordisk Investigational Site

    Nijmegen, Netherlands

  • Novo Nordisk Investigational Site

    Utrecht, Netherlands

  • Novo Nordisk Investigational Site

    Warsaw, Poland

  • Novo Nordisk Investigational Site

    Madrid, Spain

  • Novo Nordisk Investigational Site

    Bangkok, Thailand

  • Novo Nordisk Investigational Site

    Bornova-IZMIR, Turkey (Türkiye)

  • Novo Nordisk Investigational Site

    Dnipropetrovsk, Ukraine

  • Novo Nordisk Investigational Site

    Lviv, Ukraine

  • Novo Nordisk Investigational Site

    London, United Kingdom

  • Novo Nordisk Investigational Site

    London, United Kingdom

  • Novo Nordisk Investigational Site

    Sheffield, United Kingdom

  • Novo Nordisk Investigational Site

    Southampton, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.